Directorate change
Directorate change
February 29, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Susan Kilsby, Chairman of the Company, is to be appointed Chairman of the Nomination Committee with effect from the conclusion of the Annual General Meeting to be held on April 28, 2016.
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
|
Investor Relations | ||
|
Sarah Elton-Farr | [email protected] | +44 1256 894157 |
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.